Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background and aim Previous studies showed that renal dysfunction was associated with both a reduction in serum high-density lipoprotein (HDL) cholesterol concentration and increased circulating monocyte count. We aimed to investigate the effect of circulating monocyte to serum HDL cholesterol ratio (M/H ratio) on fatal and composite cardiovascular events, in an observational cohort study of chronic kidney disease (CKD) patients.Materials and methods A total of 340 subjects with stage 1-5 CKD were followed for a mean follow-up period of 33 (range 2-44) months and assessed for fatal and nonfatal CV events. M/H ratio was calculated for all patients. All-cause mortality and CVE were also analyzed in relation to M/H ratio.Results Monocyte/HDL cholesterol ratio was negatively correlated with estimated glomerular filtration rate (eGFR) (r = -0.43, P < 0.001). Notably, both fatal and combined fatal and nonfatal cardiovascular events were more common in patients having a M/H ratio in the third tertile was associated with a hazard ratio of 2.24 and 4.91, respectively, for fatal and composite cardiovascular events compared to being in the first tertile.Conclusion Monocyte/HDL cholesterol ratio was increased with decreasing eGFR in predialytic CKD patients. Most importantly, we report for the first time that an increased M/H ratio was cross-sectionally associated with a worse cardiovascular profile and arose as independent predictors of major cardiovascular events during follow-up.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and through multivariate analysis, this ratio was found to be an independent predictor of low FFR values [26].”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [26]
In the citing paper
“It was demonstrated that patients with hemodynamically significant stenosis (FFR ≤ 0.80) had higher MHR values, and through multivariate analysis, this ratio was found to be an independent predictor of low FFR values [26].”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [26]
Citations
Cites
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Massry, S. G., Coburn, J. W., Chertow, G. M., Hruska, K. A., Langman, C. B., Malluche, H. H., Martin, K. J., McCann, L. M., McCarthy, J. T., Moe, S. M., et al. (2003) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2,527
(2007) · The Lancet · doi:10.1016/s0140-6736(07)61778-4 · Cited by 2,331 · cited 2×
“In the presence of excessive metabolic and oxidative stress (such as in uremia), HDL might lose its protective effect and may behave as a pro-inflammatory molecule [12].”
BackgroundK/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.
(2003) · PubMed · Cited by 1,394
Monocytes in atherosclerosis: subsets and functions
Woollard, K. J., & Geissmann, F. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.228 · Cited by 890 · cited 1×
“Plaque macrophages account for the majority of leukocytes in plaques and are believed to be different from monocytes recruited from circulating blood [1].”
BackgroundAnsell, B. J., Navab, M., Hama, S., Kamranpour, N., Fonarow, G., Hough, G., Rahmani, S., Mottahedeh, R., Dave, R., Reddy, S. T., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103624.14436.4b · Cited by 590 · cited 1×
“Inflammatory/anti-inflammatory properties of HDL also distinguish better patients that are favorably affected by simvastatin treatment [14].”
BackgroundAdhesion mechanisms regulating the migration of monocytes
Imhof, B. A., & Aurrand-Lions, M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1375 · Cited by 584 · cited 1×
“Recruited monocytes facing fatty deposits undergo activation and accumulate as foam cells [2, 3].”
BackgroundHigh-Density Lipoprotein Reduces the Human Monocyte Inflammatory Response
Murphy, A. J., Woollard, K. J., Hoang, A., Mukhamedova, N., Stirzaker, R. A., McCormick, S. P. A., Remaley, A. T., Sviridov, D., & Chin-Dusting, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.168690 · Cited by 508 · cited 1×
“[5] showed in an experimental study that HDL and its major protein component—apolipoprotein A–I (apo A–I)—exhibit an antiinflammatory effect on human monocytes by inhibiting activation of CD11b.”
BackgroundSpeer, T., Rohrer, L., Blyszczuk, P., Shroff, R., Kuschnerus, K., Kränkel, N., Kania, G., Zewinger, S., Akhmedov, A., Shi, Y., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.009 · Cited by 310 · cited 1×
“[16] showed that symmetric dimethyl arginine (SDMA) could modify the HDL particle to mimic a damage-associated molecular pattern that activates toll-like receptor-2, linking abnormal HDL to innate immunity, endothelial dysfunction, and hypertension.”
BackgroundThe macrophage scavenger receptor at 30 years of age: current knowledge and future challenges
Greaves, D. R., & Gordon, S. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800066-jlr200 · Cited by 248 · cited 1×
“Recruited monocytes facing fatty deposits undergo activation and accumulate as foam cells [2, 3].”
BackgroundDysfunctional High-Density Lipoprotein in Patients on Chronic Hemodialysis
Yamamoto, S., Yancey, P. G., Ikizler, T. A., Jerome, W. G., Kaseda, R., Cox, B., Bian, A., Shintani, A., Fogo, A. B., Linton, M. F., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.013 · Cited by 199 · cited 2×
“[13] investigated the cellular cholesterol efflux and inflammatory response of macrophages exposed to HDL, in patients on hemodialysis treatment, compared to healthy controls.”
Background
Cited by
Items 101–200 of 284
Melekoğlu, R., Yaşar, Ş., Çelik, N. Z., & Özdemir, H. (2022) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.galenos.2022.36744 · Cited by 16
“Age (years)* 31 (20-42) 32 (18-44) 32 (20-44) 0.”
BackgroundInfluentialAvcı, İ. İ. (2018) · Northern Clinics of Istanbul · doi:10.14744/nci.2018.93653 · Cited by 16
“Higher monocyte to high density lipoprotein ratio (MHR) has been postulated as a negative prognostic marker for cardiovascular events in patients with chronic kidney disease [6].”
BackgroundLi, N., Ren, L., Wang, J. H., Yan, Y. R., Lin, Y. N., & Li, Q. Y. (2019) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2019.08.02 · Cited by 17
“The finding was consistent with Kanbay’s report, which reckoned MHR as an independent predictor of major cardiovascular injuries in chronic kidney disease patients (31).”
ResultXu, W., Guan, H., Gao, D., Pan, J., Wang, Z., Alam, M., Lian, J., & Zhou, J. (2019) · Medicine · doi:10.1097/md.0000000000017536 · Cited by 16
“It was reported that an increased MHR is associated with a worse cardiovascular outcome and is an independent predictor of major adverse cardiovascular events in chronic kidney disease patients.([15]) Subsequently, the MHR has been intensively studied in cardiovascular diseases over the past 4 years.”
BackgroundChen, J., Zhong, Z., Shi, D., Li, J., Ли, Б., Zhang, R., Zhang, P., Huang, N., Mao, H., & Li, Z. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.03.014 · Cited by 16
Pruc, M., Kubica, J., Banach, M., Świeczkowski, D., Rafique, Z., Peacock, W. F., Siudak, Z., Surma, S., Nanayakkara, P. W. B., Kurek, K., et al. (2024) · Kardiologia Polska · doi:10.33963/v.phj.102773 · Cited by 15
Shi, W., Wang, H., Chen, S., Guo, X., Zhao, L., & Sun, Y. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0406 · Cited by 15
Cernaro, V., Calabrese, V., Loddo, S., Corsaro, R., Macaione, V., Ferlazzo, V. T., Cigala, R. M., Crea, F., Stefano, C. D., Gembillo, G., et al. (2022) · International Urology and Nephrology · doi:10.1007/s11255-022-03137-0 · Cited by 15
“MHR is associated with the risk of cardiovascular events also in CKD populations [47, 48].”
BackgroundYildirim, F., Yıldız, A. B., & Kanbay, M. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac084 · Cited by 17
“Future studies should assess whether intervention based on the TyG improves outcomes [18].”
Self-citationMonocyte/HDL ratio predicts hypertensive complications
Kaplan, I. G., Kaplan, M., Abacıoğlu, Ö. Ö., Yavuz, F., & Saler, T. (2020) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2020_018 · Cited by 14
“The MHR is shown to be an independent predictor of increased cardiovascular events in patients with chronic renal failure, and to be associated with a poor prognosis for cardiovascular mortality (13).”
BackgroundXu, W., Guan, H., Gao, D., Wang, Z., Ba, Y., Yang, H., Shen, W., Lian, J., & Zhou, J. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s279814 · Cited by 18
Wu, D., Chen, G., Lan, Y., Chen, S., Ding, X., Wei, C., Balmer, L. A., Wang, W., Wu, S., & Xu, W. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04895-4 · Cited by 14
“…cholesterol (HDL-C) ratio (MHR), derived from routine blood and lipid tests, has emerged as a novel biomarker for metabolic inflammation [14], because of its potential to indicate deteriorations in proinflammatory status that are enhanced by an imbalance of monocytes and deficiency of…”
BackgroundDemirbaş, A., & İslamoğlu, Z. G. K. (2020) · Dermatologic Therapy · doi:10.1111/dth.14013 · Cited by 13
“Kanbay et al reported that higher MHR is a poor prognostic factor for the incidence of cardiovascular in patients with chronic kidney disease.(17) Açıkgöz et al revealed that MHR might be a marker of inflammation in BD and an early predictor of vascular involvement in these patients.”
BackgroundXing, Y., Cai, J., Qin, J.-J., Zhou, W., Li, C., & Li, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.577253 · Cited by 13
Pei, G., Liu, R., Wang, L., He, C., Fu, C., & Wei, Q. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03461-y · Cited by 13
“High MHR was one of the independent predictors of cardiovascular events in patients with chronic kidney diseases [12].”
BackgroundSucato, V., Comparato, F., Ortello, A., Galassi, A. R., & Novo, G. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14050460 · Cited by 12
“It was demonstrated that patients with hemodynamically significant stenosis (FFR ≤ 0.80) had higher MHR values, and through multivariate analysis, this ratio was found to be an independent predictor of low FFR values [26].”
BackgroundInfluentialHe, L., Chen, S., Zhu, X., & He, F. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2024.1523581 · Cited by 12
Cardioprotective Role for Paraoxonase-1 in Chronic Kidney Disease
Dube, P. R., Khalaf, F. K., DeRiso, A. C., Mohammed, C. J., Connolly, J. A., Battepati, D., Lad, A. C., Breidenbach, J. D., Kleinhenz, A. L., Khatib-Shahidi, B. Z., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10092301 · Cited by 12
“The dysfunctional high-density lipoprotein (HDL) has emerged as a potential central theme in contributing to the disproportionate cardiovascular morbidity and mortality in CKD [27].”
BackgroundYan, S., Sha, S., Wang, D., Li, S., & Jia, Y. (2022) · Coronary Artery Disease · doi:10.1097/mca.0000000000001208 · Cited by 12
Miao, T., Lou, X.-Z., Dong, S., Zhang, X., Guan, W., Zhang, Y., Li, L., Yuan, X., Ma, D., & Nan, Y. (2024) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s439397 · Cited by 13
Adili, A., Wang, Y., Zhu, X., Cao, H., Fan, F., Tang, X., Zhou, Q., & Wang, D. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23595 · Cited by 12
“Duration of AF history (month) 24 (6-120) 24 (2-102) .”
BackgroundCeyhun, G., & Engin, M. Ç. (2020) · Angiology · doi:10.1177/0003319720965808 · Cited by 12
“In addition, the MHR has been associated with the severity of atherosclerosis and cardiovascular events.(5) The MHR has been investigated in many cardiac vascular diseases, but to our knowledge, its association with PAD has not yet been evaluated.”
BackgroundResultInfluentialThe association between monocyte HDL ratio and albuminuria in diabetic nephropathy
Efe, F. K. (2021) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.37.4.3882 · Cited by 12
Türkkan, E., Dağ, N. Ç., Arabacı, Ç., Dikker, O., & Dağ, H. (2021) · Iberoamerican Journal of Medicine · doi:10.53986/ibjm.2022.0002 · Cited by 12
“It has been reported that the change in the monocyte/HDL-cholesterol ratio is associated with cardiovascular diseases [34], obesity, and metabolic syndrome [21, 22].”
BackgroundLópez‐Moreno, M., Garcés‐Rimón, M., Miguel, M., Martínez, E. F., & López, M. T. I. (2023) · Nutrients · doi:10.3390/nu15214685 · Cited by 11
“Kanbay et al. (2014) [35] first observed that MHR was a predictor of cardiovascular events in patients with chronic kidney disease (CKD).”
BackgroundWu, X., Zhang, Y., Jiang, H., & Zhang, X. (2024) · Sexual Medicine · doi:10.1093/sexmed/qfae025 · Cited by 12
“15 However, it has been shown that high-density lipoprotein cholesterol (HDL-C) counteracts the proinflammatory and pro-oxidative effects of monocytes 16,17 and also inhibits monocyte activation and the proliferation and differentiation of monocyte progenitors.”
BackgroundLiu, S., Miao, X., Hu, M., Song, Z., Xie, X., Sun, Y., Li, M., Tang, G., & Leng, S. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.037210 · Cited by 10
Evaluación de los marcadores de inflamación en el prolapso de la válvula mitral
Yalim, Z., & Ersoy, Í. (2021) · Archivos de cardiología de México · doi:10.24875/acm.21000127 · Cited by 10
Yalçın, M. S., Yalakı, S., Ölmez, Ş., & Taş, A. (2022) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2022.21401 · Cited by 10
Nam, K., Kwon, H., Jeong, H., Park, J., & Min, K. (2024) · BMC Neurology · doi:10.1186/s12883-023-03524-9 · Cited by 11
“The monocyte-to-high-density lipoprotein (HDL) cholesterol ratio is also one of these novel markers [16].”
BackgroundMethodSatılmış, S. (2017) · Northern Clinics of Istanbul · doi:10.14744/nci.2017.35761 · Cited by 10
Could the monocyte/HDL cholesterol ratio be an early marker of erectile dysfunction?
Çimen, S., Dursun, M., Sulukaya, M., & Beşiroğlu, H. (2019) · The Aging Male · doi:10.1080/13685538.2019.1574735 · Cited by 10
“Research has shown that MHR was superior to the monocyte count alone, or HDL-C levels alone in predicting the CVDs arising as a result of endothelial dysfunction [18,19].”
BackgroundKayhan, S., Kirnap, N. G., & Taştemur, M. (2020) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000668 · Cited by 10
altunel, O. (2021) · Beyoglu Eye Journal · doi:10.14744/bej.2021.94547 · Cited by 11
“In recent studies, researchers have investigated MHR in relation to diseases such as chronic kidney disease, cardiovascular disease, and endothelial dysfunction (16-20).”
BackgroundMeng, H., Zhou, X., Li, L., Liu, Y., Liu, Y., & Zhang, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-81818-9 · Cited by 9
Açar, B., Yayla, Ç., Gül, M., Karanfil, M., Ünal, S., Uçar, F. M., Kuyumcu, M. S., Ertem, A. G., Özen, Y., Özbay, M. B., et al. (2021) · African Health Sciences · doi:10.4314/ahs.v21i1.14 · Cited by 9
“Maximal Aortic Gradient (mmHg) 26 (4-110) 31 (5-138) 0.”
Moise, L., Marta, D. S., Raşcu, A., & Moldoveanu, E. (2018) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2018.36 · Cited by 10
“Similarly to Lp-PLA2, MHR was identified as a novel inflammation marker used as an independent predictor of CVD severity (30, 31).”
BackgroundEvaluation of inflammatory markers in patients with migraine
Tekeşin, A., & Tunç, A. (2019) · ARCHIVES OF CLINICAL AND EXPERIMENTAL MEDICINE · doi:10.25000/acem.494415 · Cited by 9
“It has been shown to be an independent predictor of cardiovascular events in chronic renal failure patients and poor prognosis for cardiovascular mortality [9].”
BackgroundAmouzegar, A., Mirzaasgari, Z., Mehrabi, A., Malek, M., Alaei-Shahmiri, F., Najafi, L., & Khajavi, A. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01246-6 · Cited by 9
“MHR has been reported to be linked to cardiovascular (CV) events in individuals with chronic kidney disease (CKD) in earlier investigations [12].”
BackgroundGheorghe-Milea, A., Stănoiu-Pînzariu, O., & Georgescu, C. E. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1563967 · Cited by 9
“MHR is an emerging composite biomarker that re fl ects the interplay between in fl ammation and oxidative stress, with higher values being associated with increased cardiovascular risk, particularly in individuals with chronic kidney disease (91, 92).”
Wu, Q., & Mao, W. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24007 · Cited by 8
Ning, Z., Yi, H., Yang, T., Liu, J., Su, S., He, T., Huang, H., Xie, M., Li, H., Tang, Y., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-14373-9 · Cited by 7
“The monocyte-to-high-density lipoprotein cholesterol ratio (MHR) was first proposed in a study on cardiovascular adverse events in patients with chronic kidney disease and is considered a new biomarker that reflects the degree of inflammation and oxidative stress [11].”
Association between monocyte to HDL cholesterol ratio and mitral annulus calcification
Pamukçu, H. E., & Aker, M. (2019) · Journal of Surgery and Medicine · doi:10.28982/josam.512374 · Cited by 7
Zhong, J., Huang, Z., Tang, X., Peng, L., Zhang, A., Zhang, H., & Li, S. (2022) · International Heart Journal · doi:10.1536/ihj.21-681 · Cited by 7
Doğan, Z., Bektaşoğlu, G., Dümür, Ş., Uzun, H., Erden, İ., & Yurtdaş, M. (2023) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20221211 · Cited by 7
Çakır, I. (2020) · Journal of Clinical Practice and Research · doi:10.14744/etd.2020.32549 · Cited by 7
Biomarkers of oral subacute toxicity of deltamethrin in exposed male Albino rats
Elbanna, R., Osman, K. A., & Salama, M. S. (2023) · Toxicology and Industrial Health · doi:10.1177/07482337231209360 · Cited by 6
“…lipoprotein, and neutrophil to lymphocyte platelet are commonly used as predictive markers of in fl am-matory status (Elhosary and Abdelbar, 2018; Fois et al., 2020; Jeong and Sun, 2020; Kanbay et al., 2014; Mu et al., 2021; Ortiz-López et al., 2022; Wang et al., 2019; Zhou et al., 2016).”
MethodPredictive Value of MHR and NLR for Ulcerative Colitis Disease Activity
Liu, T., Qin, Z., Yang, Z., & Feng, X. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s446723 · Cited by 6
Chen, M., Wu, J., Ma, H., Luo, L., Liu, L., Zhang, J., Wang, Y., & Xu, Y. (2025) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.70010 · Cited by 6
Kim, D., Kim, D. W., Lee, Y. H., Park, S. Y., Song, Y. W., Shin, H., Yoon, H. E., Park, H. S., Choi, B. S., Kim, B., et al. (2021) · Journal of International Medical Research · doi:10.1177/03000605211058861 · Cited by 6
Aydın, F. Y., Eynel, E., Oruç, İ., İnce, H., Yüksel, E., & Aydın, E. (2021) · Cureus · doi:10.7759/cureus.20345 · Cited by 6
“demonstrated that MHR increased in parallel to estimated glomerular filtration rate (eGFR) reduction [19,20].”
BackgroundComparison of the different PCOS phenotypes based on monocyte to HDL cholesterol ratio
Soysal, C., Bıyık, İ., İnce, O., Erten, Ö., Taşçı, Y., & Keskın, N. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2022.2026309 · Cited by 6
“MHR has been shown to be a new predictor in the prognosis of some inflammatory diseases (Kanbay et al. 2014; Canpolat et al. 2016).”
BackgroundWang, J.-R., Zhao, H., Chang, L.-J., Xu, X., Gao, Y., Li, M., Kong, Q., Wang, M.-M., & Zhao, C. (2023) · European Journal of Pediatrics · doi:10.1007/s00431-023-05122-w · Cited by 6
“…Kanbay et al. first reported that an increased MHR was cross-sectionally associated with a worse cardiovascular profile, and in their study, they confirmed that MHR could be used as a novel prognostic biomarker for the occurrence of CVDs during follow-up in patients with chronic kidney disease [8].”
BackgroundResultYashilha, D., Shini Rubina, S. K., Nanda Kumar, R., & Anuba, P. A. (2023) · Cureus · doi:10.7759/cureus.45783 · Cited by 6
“They determined this ratio to be an independent risk factor for chronic renal patients in major cardiovascular events in terms of poor prognosis [30].”
BackgroundCorrelation between GPR, MHR and elderly essential hypertension with unstable angina pectoris.
Liu, X., Zhang, Y., Fengbiao, J., Liu, H., Li, Q., Gao, Y., Hou, R., & Zhang, Z. (2021) · PubMed · doi:10.11817/j.issn.1672-7347.2021.200222 · Cited by 6
Relationship between Monocytes and Stenosis-Related Autologous Arteriovenous Fistula Dysfunction
Li, C., Li, Q., Ou, J., Li, W., Guan, B., Lu, Y.-P., Chen, Y., Hocher, B., Hu, B., & Yin, L. (2021) · Blood Purification · doi:10.1159/000514059 · Cited by 6
Sun, J., Lu, Y. Q., Shen, L., Xu, D., Sha, W., Zhou, L., & Li, J. (2023) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.13978 · Cited by 6
“MHR was first reported by Kanbay et al [22] in their study of cardiovascular events in CKD patients, which found that MHR TABLE 6 All-cause mortality risk factor analysis (one-way COX regression).”
MethodInfluentialAlızade, E., Avcı, A., Güner, A., Tabakçı, M. M., Zehir, R., Güler, A., İzci, S., & Pala, S. (2016) · Koşuyolu Heart Journal · doi:10.5578/khj.20996 · Cited by 5
“Using a cut-off level of 90.6, pre-procedural MHR predicted the presence of slow coronary fl ow (SCF) with a sensitivity of 78% and specifi city of 70%.”
BackgroundInfluentialKaynak, Ç., Özmen, E., & Aslan, M. (2025) · Nigerian Journal of Clinical Practice · doi:10.4103/njcp.njcp_252_24 · Cited by 5
Koçak, N., Yeter, V., & Güngör, İ. (2020) · Neuro-Ophthalmology · doi:10.1080/01658107.2020.1733618 · Cited by 5
“MHR has been previously evaluated as a new inflammatory biomarker in patients with endothelial dysfunction, chronic kidney disease and cardiovascular diseases.(15,26,27) It has been suggested that MHR values are superior to other blood parameters in evaluating inflammatory disorders.”
BackgroundKızılgül, M., Çalışkan, M., Uçan, B., Beysel, S., Takır, M., Sencar, M. E., Sakız, D., Çakal, E., & Özbek, M. (2018) · Medeniyet Medical Journal · doi:10.5222/mmj.2018.59837 · Cited by 5
Monocyte-to-HDL ratio and non-HDL cholesterol were predictors of septic shock in newborns
da Fonseca, F. A. M., Espósito, A. P., da Silva, M. H. B. N., Nunes, V. S., Cazita, P. M., Ferreira, G. D. S., Ceccon, M. E. J. R., de Carvalho, W. B., Carneiro-Sampaio, M. M. S., & Palmeira, P. (2022) · Clinics · doi:10.1016/j.clinsp.2022.100111 · Cited by 5
“In this context, it was reported that high circulating monocyte counts and reduced HDLc concentrations, both used to define the monocyte-to-HDL (M/H) ratio, are a recently defined parameter in the diagnosis of cardiovascular diseases and may predict adverse outcomes in patients with chronic kidney disease.(12,13) Howe…”
BackgroundKaymak, D., Oruc, S. B. B., & Davutoğlu, E. A. (2025) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-025-03992-7 · Cited by 4
“A high MHR value, along with elevated monocyte levels and low HDLc levels, may signify increased inflammation [13].”
Katipoğlu, B., Ateş, İ., Demir, B. F., Yırgın, G., Yılmaz, N., & Dede, F. (2019) · Turkish Journal of Nephrology · doi:10.5152/turkjnephrol.2019.3203 · Cited by 4
“Other studies have examined the role of the MHR in chronic kidney failure (16).”
BackgroundHuang, Z., Liu, Y., Wu, Y., Chen, P., Li, G., Wang, L., & Chen, J. (2021) · Sleep And Breathing · doi:10.1007/s11325-020-02262-3 · Cited by 4
Erdem, B., & Kaya, Y. (2021) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-021-01024-5 · Cited by 4
Erden, E., Turk, A., & Erden, E. (2023) · Nigerian Journal of Clinical Practice · doi:10.4103/njcp.njcp_875_22 · Cited by 5
Wang, L., Liu, Y., Shi, W., Liu, X., & Qin, M. (2024) · Lipids · doi:10.1002/lipd.12395 · Cited by 4
Huang, W., Wang, L., & Wan, X. H. (2021) · Perfusion · doi:10.1177/02676591211041945 · Cited by 4
Mercean, D. B., Tomoaia, R., Șerban, A. M., Mot, S. D. C., Hagiu, R., & Mihu, C. M. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13060989 · Cited by 4
“The MHR has emerged as a valuable addition to the current markers as it is easily accessible and reflects both inflammation and oxidation [14].”
BackgroundKılıç, M., Erkan, A., Zengin, S., Dündar, G., & Boyacı, Ç. (2023) · Korean journal of urology · doi:10.4111/icu.20230013 · Cited by 4
“Due to the close relationship between ED and CVD, hematological and biochemical inflammation parameters that can be used to predict or evaluate CVD have also been hypothesized to be of great clinical importance for ED, with their validity having been demonstrated by many studies [9,11,12,23-25].”
BackgroundInfluential[Atherogenic index and its association with acute coronary ischemic syndrome mortality].
Rodríguez-Martínez, B. S., Hernández-González, M. A., Borrayo–Sánchez, G., Solorio, S., Medina-Torres, Ó. M., Gutiérrez-Galván, M. X., la Roca-Chiapas, J. M. D., Cruz-Aceves, I., & Fernández-Hernández, J. P. (2023) · PubMed Central · Cited by 4
Sucato, V., Fazio, L. D., Madaudo, C., Vadalà, G., D’Agostino, A., Evola, S., Novo, G., Corrado, E., & Galassi, A. R. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11050146 · Cited by 5
Dığış, M., Tosun, M., Güner, R. Y., & Akyol, M. (2024) · Turkiye Klinikleri Journal of Dermatology · doi:10.5336/dermato.2023-97752 · Cited by 3
Inflammation as a link between depression and metabolic syndrome
Gorbunova, A. P., Rukavishnikov, G. V., & Mazo, G. E. (2024) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2024-1005 · Cited by 4
Comparison Of Monocyte / HDL Ratio In Routine Hemodialysis And Peritoneal Dialysis Patients
Alper, S. A. R. I., Ulu, M. S., Kazan, S., Tunca, O., & Kazan, E. D. (2020) · Dicle Medical Journal / Dicle Tip Dergisi · doi:10.5798/dicletip.706097 · Cited by 3
“VLDL(mg/dL) 25,28 (10-86) 37,15 (18-79) 0,312**”
Dzis, I., Tomashevska, O., Dzis, Y., & Korytko, Z. (2020) · Acta Haematologica Polonica · doi:10.2478/ahp-2020-0008 · Cited by 3
Yang, N., Hu, L., & Han, Y. (2023) · Medicine · doi:10.1097/md.0000000000035338 · Cited by 3
“[45] The association of the MHR with AIS compared with cardiovascular disease has not been fully elucidated.”
BackgroundNiu, Y., Wang, G., Feng, X., Niu, H., Shi, W., & Shen, Y. (2024) · Lipids · doi:10.1002/lipd.12385 · Cited by 3
Lin, H., Shen, H., Wang, N., & Wu, T. (2024) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2024.108228 · Cited by 3
Potential of Monocyte Count for the Assessment of Cardiovascular Disease
Matsumura, T., Yamamoto, E., Tsujita, K., & Araki, E. (2017) · Cardiovascular Pharmacology Open Access · doi:10.4172/2329-6607.1000217 · Cited by 3
“In the study focused on MHR, increased MHR was associated with a worse cardiovascular profile and arose as independent predictors of major cardiovascular events in patients with chronic kidney disease [44].”
BackgroundSerçelik, A., & Besnili, A. F. (2018) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2017.06.018 · Cited by 3
Evaluation of inflammation markers in mitral valve prolapse
Yalım, Z., & Ersoy, İ. (2022) · Archivos de cardiolog�a de M�xico (English ed Internet) · doi:10.24875/acme.m22000313 · Cited by 3
Li, Y., Xi, L., & Li, L. (2024) · Archives of Medical Science · doi:10.5114/aoms/178013 · Cited by 3
“Previous research by Kanbay et al. [32] suggested MHR as a predictor of cardiovascular events in chronic kidney disease patients.”
MethodSuzuki, H., Nagano, H., Kawagoe, K., Miura, I., & Masamoto, K. (2025) · GeroScience · doi:10.1007/s11357-025-01700-y · Cited by 2
“Therefore, high circulating monocyte counts and reduced HDL concentrations together predict adverse cardiovascular events in patients with chronic kidney disease [25].”
Gembillo, G., Soraci, L., Luciani, F., Catalano, A., Filice, L., Biscetti, L., Chinigò, C., Muglia, L., Princiotto, M., Lattanzio, F., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07745-7 · Cited by 2
“Increased MHR values have been associated with CKD presence and progression [11], resistant hypertension among patients with CKD [12], decreased estimated glomerular filtration rate (eGFR) values [13], and a higher prevalence of diabetes, CKD and cardiorenal syndromes in middle-aged adults [14–18].”
A New Hematological Marker for Idiopathic Tinnitus: Monocyte/HDL ratio
Koçak, H. E., Acıpayam, H., & Kaya, K. H. (2017) · Polski Przegląd Otorynolaryngologiczny · doi:10.5604/01.3001.0010.0900 · Cited by 2
Dolapoğlu, A., Avcı, E., & Kızılgül, M. (2018) · The Anatolian Journal of General Medical Research · doi:10.5222/terh.2018.94546 · Cited by 2
Relationship between elevated monocyte-HDL ratio, an inflammatory marker, with smoking
Köylü, E., & Kurtoğlu, Y. K. (2021) · The Journal of Turkish Family Physician · doi:10.15511/tjtfp.21.00022 · Cited by 3
“Kardiyovasküler hastalıklarda yeni tanınan inflamasyona dayalı tanısal ve prognostik bir belirteç olarak kabul edilmektedir.(29-32) Açıkgöz ve ark.”
Karotis Arter Hastalığı İçin Ümit Verici Bir Marker: Monositin High Density Lipoproteine Oranı (MHR)
Kirişçi, M. (2020) · Sakarya Medical Journal · doi:10.31832/smj.644699 · Cited by 2
Özer, H., Aydoğan, K. Z., Öztürk, Y., Yönet, F., & Baloğlu, İ. (2023) · Genel Tıp Dergisi · doi:10.54005/geneltip.1206894 · Cited by 2
The importance of inflammatory biomarkers in ischemic stroke patients with carotid artery stenosis
Tekeşin, A. (2023) · Northern Clinics of Istanbul · doi:10.14744/nci.2023.87003 · Cited by 2
“The MHR is a poor prognosis for cardiovascular mortality and it is an independent predictor of cardiovascular diseases in chronic renal failure [9].”
BackgroundXu, S., Guan, Y.-M., Xuan, H.-Y., Fan, X.-F., Lu, P., & Li, H. (2025) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s511635 · Cited by 2
Yılmaz, A. C., & Yılmaz, H. (2025) · International Journal of Ophthalmology · doi:10.18240/ijo.2025.06.10 · Cited by 2
“Studies have shown that MHR is associated with a number of diseases such as cardiovascular disease, endothelial dysfunction, and chronic kidney disease [60-61] .”
Sökmen, E., & Çelık, M. (2019) · Turkish Journal of Clinics and Laboratory · doi:10.18663/tjcl.541023 · Cited by 2
Özdemir, S., & Algın, A. (2021) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/jcmk/11326 · Cited by 2
“46 Journal of Clinical Medicine of Kazakhstan: 2021 Volume 18, Issue 6 ACS [7-11].”
BackgroundInfluentialSavaş, G., Aslan, M. S., Kızılay, M., Yüksel, G., Aydogdu, U., & Terzi, S. (2022) · Journal of Cardiac Surgery · doi:10.1111/jocs.16315 · Cited by 2
Avcı, A. (2022) · International journal of medical biochemistry/International journal of medical biochemistry : · doi:10.14744/ijmb.2022.20981 · Cited by 2
Significance of laboratory biomarkers in monitoring patients with COVID-19 pneumonia
Ölmez, H., & Tosun, M. (2023) · Health Sciences Quarterly · doi:10.26900/hsq.1771 · Cited by 2
Neutrophil-to-Lymphocyte ratio and Monocyte-to-HDL ratio as a Biomarker of Urolithiasis
Butt, A. J., Khawar, M. B., Afzal, A., Bhalli, A. U., Hashmi, M. A. T. S., Afzal, N., Hamid, S. E., Shahzaman, S., Habiba, U., & Shah, S. S. (2023) · Comparative Clinical Pathology · doi:10.1007/s00580-023-03488-9 · Cited by 2
Metadata
- Authors
- Kanbay, M., Solak, Y., Unal, H. U., Kurt, Y. G., Gok, M., Cetinkaya, H., Karaman, M., Oguz, Y., Eyileten, T., Vural, A., Covic, A., Goldsmith, D., Turak, O., & Yilmaz, M. I.
- Affiliations
- Istanbul Medeniyet University (TR)
- Gülhane Askerî Tıp Akademisi (TR)
- Spitalul Clinic Dr. C. I. Parhon (RO)
- St Thomas' Hospital (GB)
- Türkiye Yüksek İhtisas Hastanesi (TR)
- Corresponding author
- Kanbay, Mehmet
- Venue
- International Urology and Nephrology
- Published
- 2014-05-23
- Volume
- 46
- Issue
- 8
- Pages
- 1619-1625
- ISSN
- 0301-1623 (ISSN-L)
- 1573-2584
- OpenAlex
- W2035731392
- Cited by
- 276
- References
- 17
- Citations by year
- 2026: 9 · 2025: 24 · 2024: 32 · 2023: 34 · 2022: 30 · 2021: 34 · 2020: 31 · 2019: 27 · 2018: 18 · 2017: 13 · 2016: 17 · 2015: 6
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Urology and Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- monocyte count, HDL cholesterol, chronic kidney disease, cardiovascular events, all-cause mortality, estimated glomerular filtration rate, cardiovascular risk prediction
- MeSH terms
- Adult, Aged, Cardiovascular Diseases, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic, Leukocyte Count, Cholesterol, HDL, Male, Middle Aged, Monocytes, Myocardial Infarction, Prospective Studies, Stroke, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.